Territory Manager - Surgical Vision
About the job
- A tertiary qualification within Business, Medical, Health Sciences, or a related field is required.
- At least 3 years of medical device or hospital pharmaceutical sales experience is required.
- A keen interest in Ophthalmology and a demonstrated track record of strong commercial achievements are required.
- Commercial acumen and a positive, results-oriented attitude are required.
- Excellent communication skills and the ability to influence different stakeholders and build long-term relationships are required.
- The ability to work independently and collaboratively, with strong organizational skills, is required.
- Applicants must have the right to work in Australia, a reliable car, and a valid driver's license.
- Drive sales growth and achieve territory targets by promoting the company's cataract portfolio to hospitals, day surgeries, and ophthalmic specialists.
- Build trusted partnerships with surgeons and clinical stakeholders, providing education and support on cataract products and technologies to improve patient outcomes.
- Identify new business opportunities, monitor market trends and competitor activity, and implement strategies to maximize territory performance.
- Collaborate with marketing, professional education, and clinical specialists to execute commercial initiatives, customer engagement activities, and educational events.
- Manage customer accounts, CRM data, consignment inventory, and business resources to deliver customer service and achieve business objectives.
- Travel frequently to hospitals within the Gold Coast region.
About the company
Johnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.
Company Size
10,001+
Company Stage
IPO
Headquarters
New Brunswick, New Jersey
Founded
1886
Get referred to Johnson & Johnson
See people who can refer or advise you
Simplify's Take
What believers are saying
- Cancer drugs drive growth: oncology sales rose 17% to $7.4 billion in the June 2026 quarter, 29% of the total.
- Stock grants have gained value: J&J shares rose 58% in the year to September 2026, versus 23% for Pfizer.
- Students have a way in: J&J listed 1,897 open jobs in October 2026, including 201 internships, co-ops and early-career roles.
What critics are saying
- Its key immune drug trails: AbbVie's Skyrizi outsold Tremfya $5.5 billion to $2.0 billion in the June 2026 quarter.
- Orthopedics is leaving J&J: in September 2026, it was negotiating a $20 billion sale to buyout firm Apollo.
- Baby powder suits remain costly: in July 2026, J&J agreed to pay $5.5 billion to end about 76,000 cancer claims.
What makes Johnson & Johnson unique
- Its debt is rated safer than America's: S&P's top AAA rating goes to only two US companies, J&J and Microsoft.
- Employees rank above shareholders: J&J's 1943 Credo lists duties to patients, then staff and communities, with stockholders last.
- Its psoriasis pill is a first: Icotyde, approved March 2026, blocks an immune signal rivals target only by injection.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- 401(k) Retirement Plan
- 401(k) Company Match
- Paid Vacation
- Paid Sick Leave
- Paid Holidays
- Remote Work Options
- Performance Bonus